Mirowski G, Austen K F, Chiang L, Horan R F, Sheffer A L, Weidner N, Murphy G F
Harvard School of Dental Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Lab Invest. 1990 Jul;63(1):52-62.
Biopsies of lesional and nonlesional skin from 14 patients with localized cutaneous or associated systemic mastocytosis were examined by ultrastructural and immunohistochemical techniques. Mast cells within lesions of the dermis were highly variable between patients with regard to cell number and extent of degranulation, although lesional sites consistently contained more mast cells than did nonlesional sites. Two mast cell patterns were identified based upon granule morphology. In biopsies from 8 patients, the majority of granules contained electron-dense amorphous zones; crystalline lattices; and indistinct, incomplete solid scrolls forming parallel lamellae. In biopsies from 6 patients, in addition to these granules, there were also granules composed of electron-dense amorphous zones, reticulated matrices, and/or distinct scrolls with lucent cores interrupted by dense spheres. The granule morphology for the first group (N = 8) was identical with that seen in the preponderant type of skin mast cell of 6 normal control subjects, whereas the granule morphology of the second group (N = 6) displayed an abnormal ultrastructural phenotype for skin that included granule types normally found not only in skin but also in intestinal lamina propria and lung. For individual patients, the patterns of granule ultrastructure were consistent between clinically nonlesional and lesional skin. A minority of cells in both patient groups appeared primitive ultrastructurally, exhibiting rudimentary, Golgi-associated progranules; monocyte-like morphologic characteristics; and mitotic activity. Moreover, when mast cells in lesional skin were screened for a limited panel of surface antigens, they displayed common patterns of reactivity (M718+, HLA-DR/DQ+, CD4+), and in a selected case, immunoelectron microscopy confirmed the presence of these antigens on mast cell plasma membranes. Dermal mast cells from normal donors (N = 6) lack these epitopes. These observations suggest that infiltrates in cutaneous mastocytosis may exhibit phenotypic characteristics not only of cutaneous mast cells, but in some patients also of mucosal mast cells. In either circumstance, the mast cells may display antigenic determinants common to monocyte/macrophages. Concordance of granule phenotype between lesional and clinically uninvolved skin of individual patients furthers the notion that even localized mastocytosis reflects covertly defective systemic mast cell homeostasis.
采用超微结构和免疫组织化学技术,对14例局限性皮肤肥大细胞增生症或相关系统性肥大细胞增生症患者的病变皮肤和非病变皮肤活检标本进行了检查。尽管病变部位的肥大细胞数量始终多于非病变部位,但真皮病变内的肥大细胞在患者之间,在细胞数量和脱颗粒程度方面差异很大。根据颗粒形态确定了两种肥大细胞模式。在8例患者的活检标本中,大多数颗粒含有电子致密的无定形区、晶格以及形成平行薄片的不清晰、不完整的实心卷轴。在6例患者的活检标本中,除了这些颗粒外,还有由电子致密的无定形区、网状基质和/或带有被致密球体中断的透明核心的明显卷轴组成的颗粒。第一组(N = 8)的颗粒形态与6名正常对照受试者中占优势的皮肤肥大细胞类型所见相同,而第二组(N = 6)的颗粒形态显示出皮肤异常的超微结构表型,包括通常不仅在皮肤而且在肠固有层和肺中发现的颗粒类型。对于个体患者,颗粒超微结构模式在临床非病变皮肤和病变皮肤之间是一致的。两组患者中少数细胞在超微结构上表现为原始状态,呈现出未成熟的、与高尔基体相关的前颗粒、单核细胞样形态特征以及有丝分裂活性。此外,当对病变皮肤中的肥大细胞进行一组有限的表面抗原筛查时,它们表现出共同的反应模式(M718 +、HLA - DR/DQ +、CD4 +),并且在一个选定的病例中,免疫电子显微镜证实了这些抗原存在于肥大细胞膜上。正常供体(N = 6)的真皮肥大细胞缺乏这些表位。这些观察结果表明,皮肤肥大细胞增生症中的浸润细胞不仅可能表现出皮肤肥大细胞的表型特征,而且在某些患者中还可能表现出黏膜肥大细胞的表型特征。在任何一种情况下,肥大细胞可能显示出单核细胞/巨噬细胞共有的抗原决定簇。个体患者病变皮肤和临床未受累皮肤之间颗粒表型的一致性进一步支持了这样一种观点,即即使是局限性肥大细胞增生症也反映了潜在的系统性肥大细胞稳态缺陷。